More About Startup Genome Investor Compass
The Investor compass allows investors, advisors and service providers to track the progress of all the companies they work with. The Investor Compass leverages the Startup Genome methodology and database of more than 17,000 business to augment the dashboard data, including color coded benchmarks for every startup’s KPIs, a risk assessment for premature scaling and dozens of red flag due diligence tests, that would ordinarily take hours conversation and manual labor. This augmented view of a portfolio’s performance enables investors and advisors to quickly see who is doing well and who isn’t, and then decide what actions they need to take to better help their companies succeed.
To date, there haven’t been any good quantitative assessment tools for startups, so people have been forced to rely solely on intuition and social proof to evaluate early stage companies. We believe this shift to a quantitative alternative is a major step towards opening up the data driven business frontier.
Please check out the investor dashboard and let us know how you use it and how you would like to see it evolve.